Press Releases

Date	Title
2023-02-28	GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service
2022-12-15	Cell and Gene Therapy Companies Leverage GenScript’s cGMP sgRNA Capability to Accelerate Speed to Market
2022-11-21	4th GenScript Cell and Gene Therapy Industry Development & Cooperation Forum Brought together CEOs of three CAR-T companies
2022-10-18	Topping out of GenScript Life Science Reagent R&D and Manufacturing Building Fuels High-quality Growth of Biopharmaceutical Services
2022-10-17	GenScript supported approval of its partner's nasal spray for COVID-19 protection in Thailand
2022-09-22	GenScript and Gladstone-UCSF Institute of Genomic Immunology Collaborate on Groundbreaking Non-Viral Cell Therapy Study
2022-09-20	GenScript and Avectas Team Up to Improve the Non-Viral Cell Therapy Manufacturing Process
2022-05-16	GenScript Launches GMP Single-Strand and Double-Strand DNA Service for Supporting Gene and Cell Therapy Development
2021-11-30	GenScript Launches Closed-End Double Stranded DNA Service for CRISPR \| GenScript
2021-06-30	GenScript receives "Best Contract Development and Manufacturing Organization Award" in the Korea Bioprocessing Excellence Awards 2021
2021-06-21	Duke NUS and GenScript Announce Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Test \| GenScript
2021-05-12	ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement \| GenScript
2021-04-28	GenScript Launches Research-Grade Lentiviral Vector Packaging Service
2021-04-12	GenScript, Parkway Laboratories and Diagnostics Development (DxD) Hub collaborate to provide cPass™ SARS-CoV-2 Neutralizing Antibody Testing Service in Singapore
2021-03-29	GenScript Biotech Reports Full Year 2020 Financial Results and Business Results
2021-03-17	GenScript and G42 Healthcare Announce Collaboration to Provide Innovative Solutions to Fight against COVID-19 \| GenScript
2021-03-16	GenScript Receives ""Best Contract Research Organization Award"" \| GenScript
2020-11-06	GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit
2020-09-15	Innatoss Laboratories Launches Neutralizing Antibody Public Testing Service for SARS-CoV-2 in Europe using GenScript's cPass™ kit
2020-06-07	GenScript shareholder assured entitlement FAQs

SUPPORT

COMPANY

SUPPORT

COMPANY